MORGAN STANLEY - NRX PHARMACEUTICALS INC ownership

NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 27 filers reported holding NRX PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of NRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$12,304
-46.2%
47,3260.0%0.00%
Q2 2023$22,882
-26.6%
47,3260.0%0.00%
Q1 2023$31,193
-44.2%
47,326
-6.0%
0.00%
Q4 2022$55,875
+29.9%
50,338
-15.1%
0.00%
Q3 2022$43,000
+30.3%
59,313
+5.2%
0.00%
Q2 2022$33,000
-74.2%
56,365
+8.8%
0.00%
Q1 2022$128,000
-53.3%
51,797
-9.7%
0.00%
Q4 2021$274,000
-28.1%
57,344
+39.7%
0.00%
Q3 2021$381,000
-17.7%
41,052
+3.0%
0.00%
Q2 2021$463,00039,8690.00%
Other shareholders
NRX PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Texas Capital Bank Wealth Management Services Inc 63,290$41,7140.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 230,700$152,0540.00%
Virtu Financial LLC 46,210$300.00%
United Asset Strategies, Inc. 18,300$12,0620.00%
HBK Sorce Advisory LLC 29,230$19,2660.00%
UBS Group AG 18,611$12,2650.00%
NewEdge Advisors, LLC 2,125$1,4010.00%
OSAIC HOLDINGS, INC. 27,225$17,9330.00%
BANK OF AMERICA CORP /DE/ 30,000$19,7700.00%
WELLS FARGO & COMPANY/MN 5,309$3,5000.00%
View complete list of NRX PHARMACEUTICALS INC shareholders